Radiological evaluation of lymph node metastases in patients with cervical cancer: A meta-analysis

JAMA

Volumn 278, Issue 13, 1997, Pages 1096-1101

  Scheidler, Juergen ^a   Hricak, Hedvig ^a   Yu, Kyle K ^a   Subak, Leslee ^a   Segal, Mark R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHANGIOGRAPHY; MAJOR CLINICAL STUDY; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; UTERINE CERVIX CANCER;

EID: 0030821941     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.13.1096     Document Type: Review

References (84)

1. Hopkins MP, Morley GW. Stage Ib squamous cell cancer of the cervix: clinicopathologic features related to survival. Am J Obstet Gynecol. 1991;164: 1520-1529.
2. Morrow CP, Curtin JP, Townsend DE. Tumors of the cervix. In: Morrow CP, Curtin JP, Townsend DE, eds. Synopsis of Gynecologic Oncology. 4th ed. New York, NY: Churchill Livingstone; 1993:111-152.
3. Fuller AF Jr, Elliott N, Koaloff C, Hoskins WJ, Lewis JL Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol. 1989;33:34-39.
4. Downey GO, Polish RA, Adcock LL, Prem KA, Twiggs LB. Pretreatment surgical staging in cervical carcinoma: therapeutic efficacy of pelvic lymph node resection. Am J Obstet Gynecol. 1989;160:1055-1061.
5. Potish RA, Twiggs LB, Okagaki T, Prem KA, Adcock LL. Therapeutic implications of the natural history of advanced cervical cancer as defined by pretreatment surgical staging. Cancer. 1985;56:956-960.
6. Mendenhall WM, McCarty PJ, Morgan LS, Chafe WE, Million RR. Stage IB or IIA-B carcinoma of the intact uterine cervix greater than or equal to 6 cm in diameter: is adjuvant extrafascial hysterectomy beneficial? Int J Radiat Oncol Biol Phys. 1991;21: 899-904.
7. Russell AH, Shingleton HM, Jones WB, et al. Diagnostic assessments in patients with invasive cancer of the cervix: a national patterns of care study of the American College of Surgeons. Gynecol Oncol. 1996;63:159-165.
8. Montana GS, Hanlon AL, Brickner TJ, et al. Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys. Int J Radiat Oncol Biol Phys. 1995;32:1481-1486.
9. National Institutes of Health. Cervical cancer. NIH Consens Statement. 1996;14:1-38.
10. Feigen M, Crocker EF, Read J, Crandon AJ. The value of lymphoscintigraphy, lymphangiography and computer tomography scanning in the preoperative assessment of lymph nodes involved by pelvic malignant conditions. Surg Gynecol Obstet. 1987;165:107-110.
11. Heller PB, Maletano JH, Bundy BN, Barnhill DR, Okagaki T. Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis - a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38:425-430.
12. La Fianza A, Dore R, Di Giulio G, et al. Lymph node metastasis of carcinoma of the cervix uteri: role of lymphography and computerized tomography [in Italian]. Radiol Med. 1990;80:486-491.
13. Vercamer R, Janssens J, Usewils R, et al. Computed tomography and lymphography in the presurgical staging of early carcinoma of the uterine cervix. Cancer. 1987;60:1745-1750.
14. Kim SH, Choi BI, Lee HP, etal. Uterine cervical carcinoma: comparison of CT and MR findings. Radiology. 1990;175:45-51.
15. Kim SH, Choi BI, Han JK, et al. Preoperstive staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J Comput Assist Tomogr. 1993;17:633-640.
16. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol. 1995;86:43-50.
17. Ho CM, Chien TY, Jeng CM, Tsang YM, Shih BY, Chang SC. Staging of cervical cancer: comparison between magnetic resonance imaging, computed tomography and pelvic examination under anesthesia. J Formos Med Assoc. 1992;91:982-990.
18. Janus CL, Mendelson DS, Moore S, Gendal ES, Dottino P, Brodman M. Staging of cervical carcinoma: accuracy of magnetic resonance imaging and computed tomography. Clin Imaging. 1989;13:114-116.
19. Leman MH Jr, Park RC, Barham ED, Chism SE, Petty WM, Patow WE. Pretreatment lymphangiography in carcinoma of the uterine cervix. Gynecol Oncol. 1975;3:354-360.
20. Brenner DE, Whitley NO, Prempree T, Villas anta U. An evaluation of the computed tomographic scanner for the staging of carcinoma of the cervix. Cancer. 1982;50:2323-2328.
21. Walsh JW, Goplerud DR. Prospective comparison between clinical and CT staging in primary cervical carcinoma. AJR Am J Roentgenol. 1981;137: 997-1003.
22. Villasanta U, Whitley NO, Haney PJ, Brenner D. Computed tomography in invasive carcinoma of the cervix: an appraisal. Obstet Gynecol. 1983;62: 218-224.
23. Kim SH, Kim SC, Choi BI, Han MC. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology. 1994;190: 807-811.
24. Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet. 1955;20:309-314.
25. Black WC, Armstrong P. Communicating the significance of radiologic test results: the likelihood ratio. AJR Am J Roentgenol 1986;147:1313-1318.
26. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993;12: 1293-1316.
27. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature, III: how to use an article about a diagnostic test, B: what are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271:703-707.
28. Ashraf M, Elyaderani MK, Gabriele OF, Krall JM. Values of lymphangiography in the diagnosis of paraaortic lymph node metastases from carcinoma of the cervix. Gynecol Oncol. 1982;14:96-104.
29. Kindermann G, Gerteis W, Weishaar J. Achievement of lymphography in the recognition of cervix carcinoma metastases [in German]. Geburtshilfe Frauenheilkd. 1970;30:444-152.
30. Kjorstad KE, Kolbenstvedt A, Drewatne T, Orjaseter H. Lymphography and CE Ain the diagnosis of metastases in patients with stage IB cancerof the cervix. Diagn Gynecol Obstet. 1980;2:71-75.
31. Kolbenstvedt A. Lymphography in the diagnosis of metastases from carcinoma of the uterine cervix stages i and ii. Acta Radiol Diagn. 1975;16:81-97.
32. Lecart C, Lenfant P. Critical appraisal of lymphangiography in cancer of the female genital tract. Lymphology. 1971;3:100-108.
33. Smales E, Perry CM, Macdonald JS, Baker JW. The value of lymphography in the management of carcinoma of the cervix. Clin Radiol. 1986;37:19-22.
34. Stellato G, Tikkala L, Makela P, Kajanoja P. Pelvic lymph node metastases in cervical cancer: comparison of lymphography, inspection, radiography, and histologic examination of lymph nodes. Eur J Gynaecol Oncol. 1992;13:161-166.
35. Swart E, Bouma J, Schuur K. The clinical value of lymphography in cervical cancer, FIGO-stage Ib-IIa. Eur J Gynaecol Oncol. 1989;10:85-90.
36. De Muylder X, Belanger R, Vauclair R, Audet-Lapointe P, Cormier A, Methot Y. Value of lymphography in stage IB cancer of the uterine cervix. Am J Obstet Gynecol. 1984;148:610-613.
37. Camilien L, Gordon D, Fruchter RG, Maiman M, Boyce JG. Predictive value of computerized tomography in the presurgical evaluation of primary carcinoma of the cervix. Gynecol Oncol. 1988;30:209-215.
38. Grumbine FC, Rosenshein NB, Zerhouni EA, Siegelman SS. Abdominopelvic computed tomography in the preoperative evaluation of early cervical cancer. Gynecol Oncol. 1981;12:286-290.
39. Greco A, Mason P, Leung AW, Dische S, McIndoe GA, Anderson MC. Staging of carcinoma of the uterine cervix: MRI-surgical correlation. Clin Radiol. 1989;40:401-405.
40. Hawnaur JM, Johnson RJ, Buckley CH, Tindall V, Isherwood I. Staging, volume estimation and assessment of nodal status in carcinoma of the cervix: comparison of magnetic resonance imaging with surgical findings. Clin Radiol. 1994;49:443-452.
41. Brown RC, Buchsbaum HJ, Tewfik HH, Platz CE. Accuracy of lymphangiography in the diagnosis of paraaortic lymph node metastases from carcinoma of the cervix. Obstet Gynecol. 1979;54:571-575.
42. Piver MS, Wallace S, Castro JR.The accuracy of lymphangiography in carcinoma of the uterine cervix. Am J Roentgenol Radium Ther Nucl Med. 1971; 111:278-283.
43. Piver MS, Barlow JJ. Para-aortic lymphadenectomy, aortic node biopsy, and aortic lymphangiography in staging patients with advanced cervical cancer. Cancer. 1973;32:367-370.
44. King LA, Talledo OE, Gallup DG, el Gammal TA. Computed tomography in evaluation of gynecologic malignancies: a retrospective analysis. Am J Obstet Gynecol. 1986;155:960-964.
45. Van Engelshoven JM, Versteege CW, Ruys JH, de Haan J, Sanches H. Computed tomography in staging untreated patients with cervical cancer. Gynecol Obstet Invest. 1984;18:289-295.
46. Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology. 1988;166:623-631.
47. Heuck A, Scheidler J, Kimmig R, et al. Lymph node staging in cervical carcinoma: results of high resolution MRI with phased-array coil [in German]. Fortschr Roentgenstr. 1997;166:210-214.
48. Lagasse LD, Ballon SC, Berman ML, Watring WG. Pretreatment lymphangiography and operative evaluation in carcinoma of the cervix. Am J Obstet Gynecol. 1979;134:219-224.
49. Bandy LC, Clarke-Pearson DL, Silver-man PM, Creasman WT. Computed tomography in evaluation of extrapelvic lymphadenopathy in carcinoma of the cervix. Obstet Gynecol. 1985;65:73-76.
50. Matsukuma K, Tsukamoto N, Matsuyama T, Ono M, Nakano H. Preoperative CT study of lymph nodes in cervical cancer its correlation with histological findings. Gynecol Oncol. 1989;33:168-171.
51. Vas W, Wolverson M, Freel J, Salimi Z, Sundaram M. Computed tomography in the pretreatment assessment of carcinoma of the cervix. J Comput Tomogr. 1985;9:359-368.
52. Chung CK, Nahhas WA, Zaino R, Stryker JA, Mortel R. Histologic grade and lymph node metastasis in squamous cell carcinoma of the cervix. Gynecol Oncol. 1981;12:348-354.
53. Dargent D, Frobert JL, Beau G. V factor (tumor volume) and T factor (FIGO classification) in the assessment of cervix cancer prognosis: the risk of lymph node spread. Gynecol Oncol. 1985;22:15-22.
54. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38:352-357.
55. Burghardt E, Pickel H. Local spread and lymph node involvement in cervical cancer. Obstet Gynecol. 1978;52:138-145.
56. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol. 1975;46:506-510.
57. Gauthier P, Gore I, Shingleton HM, Soong SJ, Orr JW, Hatch KD. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix. Obstet Gynecol. 1985;66:569-574.
58. Van Nagell JR Jr, Roddick JW Jr, Lowin DM. The staging of cervical cancer inevitable discrepancies between clinical staging and pathological findings. Am J Obstet Gynecol. 1971;110:973-978.
59. Van Nagell JR, Donaldson ES, Parker JC, Van Dyke AH, Wood EG. The prognostic significance of cell type and lesion size in patients with cervical cancer treated by radical surgery. Gynecol Oncol. 1977;5:142-151.
60. White CD, Morley GW, Kumar NB. The prognostic significance of cell type and lesion size in patients with cervical cancer treated by radical surgery. Am J Obstet Gynecol. 1984;149:342-349.
61. Hsu CT, Cheng YS, Su SC. Prognosis of uterine cervical cancer with extensive lymph node metastases: special emphasis on the value of pelvic lymphadenectomy in the surgical treatment of uterine cervical cancer. Am J Obstet Gynecol. 1972;114:954-962.
62. Berman ML, Lagasse LD, Watring WG, et al. The operative evaluation of patients with cervical carcinoma by an extraperitoneal approach. Obstet Gynecol. 1977;50:658-664.
63. Boronow RC. Stage I cervix cancer and pelvic node metastasis: special reference to the implications of the new and the recently replaced FIGO classifications on stage Ia. Am J Obstet Gynecol. 1977;127:135-137.
64. Langley II, Moore DW, Tarnasky JW, Roberts PH. Radical hysterectomy and pelvic lymph node dissection. Gynecol Oncol. 1980;9:37-42.
65. Ballon SC, Berman ML, Lagasse LD, Petrilli ES, Castaldo TW. Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma. Obstet Gynecol. 1981;57:90-95.
66. Lee YN, Wang KL, Lin MH, et al. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer a clinical review of 954 cases. Gynecol Oncol. 1989;32:135-142.
67. Martimbeau PW, Kjorstad KE, Iversen T. Stage IB carcinoma of the cervix, the Norwegian Radium Hospital, II: results when pelvic nodes are involved. Obstet Gynecol. 1982;60:215-218.
68. Noguchi H, Shiozawa I, Sakai Y, Yamazaki T, Fukuta T. Pelvic lymph node metastasis of uterine cervical cancer. Gynecol Oncol. 1987;27:150-158.
69. Shingleton HM. Do squamous cell carcinomas and adenocarcinomas of the cervix have the same risk factors? Gynecol Oncol. 1993;51:299-300.
70. Bonanno JP, Boyce J, Fruchter R, Khulpateea N, Macasaet M, Remy JC. Involvement of paraaortic lymph nodes in carcinoma of the cervix. JAm Osteopath Assoc. 1980;79:567-571.
71. Buchsbaum HJ. Extrapelvic lymph node metastases in cervical carcinoma. Am J Obstet Gynecol. 1979;133:814-824.
72. Berman ML, Keys H, Creasman W, DiSaia P, Bundy B, Blessing J. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 1984;19:8-16.
73. Hughes RR, Brewington KC, Hanjani P, et al. Extended field irradiation for cervical cancer based on surgical staging. Gynecol Oncol. 1980;9:153-161.
74. Lagasse LD, Creasman WT, Shingleton HM, Blessing JA. Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol. 1980;9:90-98.
75. Sudarsanam A, Charyulu K, Belinson J, et al. Influence of exploratory celiotomy on the management of carcinoma of the cervix: a preliminary report. Cancer. 1978;41:1049-1053.
76. Welander CE, Pierce VK, Non D, et al. Pretreatment laparotomy in carcinoma of the cervix. Gynecol Oncol. 1981;12:336-347.
77. Nelson JH Jr, Boyce J, Macasaet M, et al. Incidence, significance, and follow-up of para-aortic lymph node metastases in late invasive carcinoma of the cervix. Am J Obstet Gynecol. 1977;128:336-340.
78. Wharton JT, Jones HWd, Day TG Jr, Rutledge FN, Fletcher GH. Preirradiation celiotomy and extended field irradiation for invasive carcinoma of the cervix. Obstet Gynecol. 1977;49:333-338.
79. Cappelleri JC, Ioannidis JPA, Schmid CH, et al. Large trials vs meta-analysis of smaller trials: how do their results compare? JAMA. 1996;276:1332-1338.
80. Irwig L, Tosteson ANA, Gatsonis C, et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med. 1994;120:667-676.
81. Kardaun JWPF, Kardaun OJWF. Comparative diagnostic performance of three radiological procedures for the detection of lumbar disk herniation. Methods Inf Med. 1990;29:12-22.
82. Midgette AS, Stukel TA, Littenberg B. A meta-analytic method for summarizing diagnostic test performance: receiver-operating-characteristic-summary point estimates. Med Decis Making. 1993; 13:253-257.
83. Vinnicombe SJ, Norman AR, Nicolson V, Husband JE. Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography [published correction appears in Radiology. 1995;196:800]. Radiology. 1995;194:349-355.
84. Vassallo P, Matei C, Heston WD, McLachlan SJ, Koutcher JA, Castellino RA. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology. 1994;193:501-506.